TopFunds

Regeneron Pharmaceuticals

NASDAQ: REGN

Stock price

784.67 USD

(+20.37%) 5 years

Biotechnology

Insider Transactions

5Y price score: 28
Help

The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.

A score of 100 indicates that the stock did as well as the S&P 500 Index.

A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.

5Y return: +20.37%
DATE RANGE:
USD PER SHARE

  • Stock price
  • Sales
  • Purchases
  • Stock awards

Transaction History

Trade log
DateActionSharesPriceShare ValueHoldingNameTitleSource
03-sep.-26Sale(1,131)857.4(969,708)12,003McCourt Marionofficer: EVP Commerciallink
02-sep.-26Sale(1,215)850.0(1,032,750)13,134McCourt Marionofficer: EVP Commerciallink
02-sep.-26Sale(400)850.0(340,000)603Guarini Kathryndirectorlink
10-aug.-26Sale(400)800.0(320,000)603Guarini Kathryndirectorlink
10-aug.-26Sale(800)800.0(640,000)1,703Zoghbi Huda Ydirectorlink
02-jul.-26Sale(200)650.2(130,030)17,303RYAN ARTHUR Fdirectorlink
01-may.-26Sale(5)701.8(3,509)17,598RYAN ARTHUR Fdirectorlink
01-may.-26Sale(15)702.5(10,537)17,583RYAN ARTHUR Fdirectorlink
01-may.-26Sale(24)703.5(16,883)17,559RYAN ARTHUR Fdirectorlink
01-may.-26Sale(15)704.3(10,564)17,544RYAN ARTHUR Fdirectorlink

541.0

52-week range

859.3

784.668

Your model inputs

Required return / cost of capital
%
FCFF terminal growth rate
%

Your fair value & Margin of safety

To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.

Forecast:

Set price notification

Valuation

Free Cash Flow Yield

Help
FCF Yield TTM = Trailing Twelve Months free cash flow per share / current market price per shareLearn more

4.2 %

Dividend Yield TTM

0.5 %

Market cap $

$ 80,838

Price / Earnings TTM

Help
P/E TTM = current market price per share / Trailing Twelve Months diluted earnings per shareLearn more

19.4

Price / Book TTM

2.6

PEG TTM

Help
Price/Earnings-to-Growth ratio = P/E TTM divided by most recent annual diluted earnings per share growth rateLearn more

2.4

Earnings growth and return

LTM

5YR

10YR

Total return (price & dividends)

31.6 %

20.9 %

92.9 %

Free cash flow per share growth

(64.9) %

115.9 %

563.2 %

Earnings per share growth

(4.8) %

35.9 %

651.4 %

Dividends

Previous dividend:0.94 per share, Paid, Ex-div date Aug 18, 2026

Analyst ratings

Price Target Low

730

Price Target High

1,030

Price Target Median

824

Buy

34

Hold

15

Sell

0

Financials

all figures in USD Millions except per share data

Periods:

View:

Forecast:

Help

Averages

based on historical growth rates (CAGR) and average margins for last 10 or max, available and up to 10 years.

Analysts

Average Revenue and Net Income forecast estimates from analysts who cover the stock.

Custom

you can edit default forecast based on averages or analysts consensus and use it to calculate fair value based on your assumptions.

ㅤ

Actual
10 year gagr
Estimated
Projected
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
2026
2027
2028
2029
2030
Terminal
FISCAL PERIOD END DATES
SHOW FORECAST VS ACTUAL
01Earnings per share
Help
Diluted EPSLearn more
5.5
7.7
10.3
21.3
18.5
30.5
72
38.2
34.8
38.3
41.5
22.4%
46.9
53.5
61
69.5
79.3
82.1
02FCF per share
5.7
8.4
8.9
15.8
17.5
17.4
58.2
39
32.3
31.8
37.6
20.8%
42.4
49.2
57
66
76.2
79
03Dividends per share
Help
Adjusted for splitsLearn more
-
-
-
-
-
-
-
-
-
-
3.5
∞%
-
-
-
-
-
-
04Dividends payout, %
-
-
-
-
-
-
-
-
-
-
8.2%
∞%
-
-
-
-
-
-
05Revenue
$ 4,104
$ 4,860
$ 5,872
$ 6,711
$ 6,558
$ 8,497
$ 16,072
$ 12,173
$ 13,117
$ 14,202
$ 14,343
13.3%
$ 16,255
$ 18,422
$ 20,877
$ 23,660
$ 26,814
$ 27,619
06ㅤ% Change
-
18.4%
20.8%
14.3%
(2.3)%
29.6%
89.1%
(24.3)%
7.8%
8.3%
1%
13.3%
13.3%
13.3%
13.3%
13.3%
13.3%
13.3%
07Net Income
636.1
895.5
1,199
2,444
2,116
3,513
8,075
4,338
3,954
4,413
4,505
21.6%
5,067
5,742
6,508
7,375
8,358
8,609
08ㅤ% Margin
15.5%
18.4%
20.4%
36.4%
32.3%
41.4%
50.3%
35.6%
30.1%
31.1%
31.4%
31.2% A
31.2%
31.2%
31.2%
31.2%
31.2%
31.2%
09CFO
1,331
1,486
1,307
2,195
2,430
2,618
7,081
5,015
4,594
4,421
4,979
14.1%
5,497
6,229
7,060
8,001
9,067
9,339
10ㅤ% Of revenue
32.4%
30.6%
22.3%
32.7%
37.1%
30.8%
44.1%
41.2%
35%
31.1%
34.7%
33.8% A
33.8%
33.8%
33.8%
33.8%
33.8%
33.8%
11CAPEX
(677.9)
(511.9)
(272.6)
(383.1)
(429.6)
(614.6)
(551.9)
(590.1)
(926.4)
(755.9)
(898.4)
2.9%
(924.1)
(950.4)
(977.6)
(1,006)
(1,034)
(1,064)
12ㅤ% Change
-
(24.5)%
(46.8)%
40.5%
12.1%
43.1%
(10.2)%
6.9%
57%
(18.4)%
18.9%
2.9% A
2.9%
2.9%
2.9%
2.9%
2.9%
2.9%
13FCFF
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities (09) – Capital Expenditures (11)Learn more
652.8
974
1,035
1,812
2,000
2,004
6,529
4,425
3,668
3,665
4,081
20.1%
4,572
5,279
6,082
6,995
8,033
8,275
14Total assets
5,609
6,974
8,764
11,735
14,805
17,163
25,435
29,215
33,080
37,759
40,559
21.9%
49,431
60,245
73,424
89,487
109,063
132,922
15ㅤ% Change
-
24.3%
25.7%
33.9%
26.2%
15.9%
48.2%
14.9%
13.2%
14.2%
7.4%
21.9%
21.9%
21.9%
21.9%
21.9%
21.9%
21.9%
16Total liabilities
1,954
2,524
2,620
2,977
3,716
6,138
6,666
6,551
7,107
8,406
9,302
16.9%
11,337
13,817
16,839
20,523
25,013
30,485
17ㅤ% Of assets
34.8%
36.2%
29.9%
25.4%
25.1%
35.8%
26.2%
22.4%
21.5%
22.3%
22.9%
22.9% A
22.9%
22.9%
22.9%
22.9%
22.9%
22.9%
18Shareholders Equity
3,655
4,449
6,144
8,757
11,090
11,025
18,769
22,664
25,973
29,354
31,257
23.9%
38,095
46,428
56,585
68,964
84,051
102,438
19Net Debt
(433.6)
(54.1)
(109.3)
(759.2)
(903.9)
502
(185.9)
(404.5)
(27.1)
216.2
(412.2)
(0.5)%
-
-
-
-
-
-
20Shares Outstanding
Help
Diluted Weighted-average Shares OutstandingLearn more
115,230
116,300
115,909
114,800
114,600
115,100
112,200
113,500
113,700
115,100
108,600
(0.6)%
107,958
107,321
106,686
106,056
105,430
104,807
21ㅤ% Change
-
0.9%
(0.3)%
(1)%
(0.2)%
0.4%
(2.5)%
1.2%
0.2%
1.2%
(5.7)%
(0.6)%
(0.6)%
(0.6)%
(0.6)%
(0.6)%
(0.6)%
(0.6)%
22ROA
11.3%
12.8%
13.7%
20.8%
14.3%
20.5%
31.8%
14.9%
12%
11.7%
11.1%
-
10.3%
9.5%
8.9%
8.2%
7.7%
6.5%
23ROE
17.4%
20.1%
19.5%
27.9%
19.1%
31.9%
43%
19.1%
15.2%
15%
14.4%
-
13.3%
12.4%
11.5%
10.7%
9.9%
8.4%
24Interest coverage
87.9
185
82.8
89.9
73.2
62.9
156.1
90.7
59.6
72.3
81.7
-
-
-
-
-
-
-
25Dividend Yield
-
-
-
-
-
-
-
-
-
-
0.5%
-
-
-
-
-
-
-
26P/E Ratio
88
42.9
33.4
17.5
19.4
14.8
8.3
17.8
23.7
17.4
17.9
-
-
-
-
-
-
-
27Stock price range
397-592
331-519
341-527
285-409
273-440
336-658
447-681
548-766
680-882
702-1202
483-787
-
-
-
-
-
-
-
28Market Cap
Help
End of Period Market CapLearn more
62,554
42,674
43,574
42,878
41,002
51,983
66,752
77,272
93,714
76,860
80,738
2.6%
96,671
106,297
116,885
128,533
141,345
-
29FCF Yield
1%
2.3%
2.4%
4.2%
4.9%
3.9%
9.8%
5.7%
3.9%
4.8%
5.1%
17.1%
4.7%
5%
5.2%
5.4%
5.7%
-
30Average stock price
494.6
425.3
433.6
346.6
356.5
497.2
563.8
657.4
781.1
951.8
635.2
2.5%
895.4
990.5
1,095.6
1,211.9
1,340.7
-
31 CEO
LS
Leonard S. Schleifer